Walgreens Boots Alliance Inc.

Walgreens Boots Alliance operates through three main segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment includes Walgreens drugstores, Duane Reade stores, and healthcare services across the United States.

The Retail Pharmacy International segment includes Boots stores and other pharmacy operations in the UK, Thailand, Norway, Ireland, Netherlands, and other international markets. The segment also includes the No7 Beauty brand and other health and beauty product lines.

The Pharmaceutical Wholesale segment, operated through Alliance Healthcare, provides wholesale distribution services to pharmacies, doctors, and healthcare providers across Europe. This segment ensures efficient distribution of pharmaceuticals and healthcare products.

Walgreens Boots Alliance employs approximately 325,000 people worldwide and generates annual revenues exceeding $130 billion. The company serves millions of customers daily through its retail pharmacies and healthcare services, making it a critical component of the healthcare delivery system.

Walgreens Boots Alliance was formed on December 31, 2014, through the merger of Walgreens and Alliance Boots, creating the first global pharmacy-led health and wellness retailer. The merger combined Walgreens, the largest drugstore chain in the United States, with Alliance Boots, a leading international pharmacy-led health and beauty retailer.

Walgreens traces its origins to 1901 when Charles R. Walgreen purchased a drug store in Chicago. The company grew throughout the 20th century, becoming one of the largest pharmacy chains in the United States through organic growth and strategic acquisitions, including the acquisition of Duane Reade in 2010.

Alliance Boots was formed in 2006 through the merger of Alliance UniChem and Boots Group. Boots was founded in 1849 by John Boot in Nottingham, England, and grew into one of the UK's leading pharmacy chains. The company expanded internationally through various acquisitions and partnerships.

The 2014 merger created a company with significant global presence, combining Walgreens' strength in the U.S. market with Alliance Boots' international footprint. The company has continued to expand through acquisitions, including the purchase of Rite Aid stores and strategic partnerships in healthcare delivery.

Throughout the 2010s and 2020s, Walgreens Boots Alliance has focused on transforming from a retail pharmacy company to an integrated healthcare provider, expanding into primary care, specialty pharmacy, and digital health services.

Walgreens Boots Alliance has implemented comprehensive sustainability initiatives focused on environmental responsibility, ethical healthcare practices, and community engagement. The company has committed to ambitious climate goals while maintaining its position as a global leader in pharmacy-led health and wellness retail.

The company has established environmental sustainability programs focusing on energy efficiency in stores and distribution centers, waste reduction initiatives, and sustainable product sourcing. Walgreens Boots Alliance has set goals to reduce carbon emissions and increase renewable energy usage across its global operations.

Walgreens Boots Alliance addresses ethical considerations through responsible pharmacy practices, medication safety programs, and healthcare accessibility initiatives. The company maintains comprehensive compliance programs for pharmaceutical distribution and retail pharmacy operations, ensuring adherence to regulatory standards and ethical business practices.

The company has strong community engagement programs, including the Walgreens Boots Alliance Foundation which supports health education, community wellness initiatives, and disaster relief efforts. Walgreens Boots Alliance employees participate in community health programs and volunteer activities, supporting public health initiatives in communities where the company operates.

Walgreens Boots Alliance has received recognition for healthcare innovation, workplace practices, and corporate responsibility:

• Fortune 500 Most Admired Companies (2024 and 2025): Recognition as one of the world's most admired companies in healthcare
• Great Place to Work Certification (2024 and 2025): Recognition for workplace culture and employee satisfaction across multiple regions
• Healthcare Innovation Awards (2023): Recognition for digital health services and pharmacy innovation
• Environmental Leadership Awards (2024): Recognition for sustainability initiatives and environmental programs
• Community Service Awards (Multiple years): Recognition for community health initiatives and employee volunteer programs
• Retail Excellence Awards (2023): Recognition for pharmacy retail innovation and customer service
• Supply Chain Excellence Awards (2023): Recognition for pharmaceutical distribution and supply chain management
• Safety Awards (2024): Recognition for workplace safety and employee well-being programs

Walgreens Boots Alliance has faced several controversies and regulatory challenges throughout 2025, primarily related to drug pricing, pharmacy practices, and regulatory compliance. The company has maintained comprehensive compliance programs while addressing various regulatory and public scrutiny issues.

Walgreens Boots Alliance has experienced product recalls affecting various pharmaceutical and over-the-counter products, working closely with regulatory agencies like the FDA to ensure consumer safety. The company maintains rigorous quality control programs and implements voluntary recall procedures when issues arise.

The company has faced extensive scrutiny regarding drug pricing practices and pharmacy benefit management relationships. Walgreens Boots Alliance has been involved in discussions and regulatory proceedings regarding prescription drug pricing transparency and reimbursement rates.

Walgreens Boots Alliance has been involved in controversies related to opioid dispensing practices and pharmacy responsibility in addressing the opioid crisis. The company has implemented enhanced monitoring programs and compliance measures to address these concerns.

The company has faced criticism regarding its retail pharmacy practices and competition with independent pharmacies, particularly concerning market consolidation and competitive practices in certain geographic markets.

Walgreens Boots Alliance has also faced scrutiny regarding its healthcare service delivery and digital health initiatives, particularly concerning data privacy and healthcare accessibility in underserved communities.